A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis | MicrobiomeTrials← Back to trialsNCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-08-15Est. Completion: 2027-12
Enrollment target: 300 participants Locations- Clinical Site, Phoenix, Arizona, United States
- Clinical Site, Scottsdale, Arizona, United States
- Clinical Site, Tucson, Arizona, United States
- Clinical Site, Anaheim, California, United States
- Clinical Site, Murrieta, California, United States
- Clinical Site, Orange, California, United States
- Clinical Site, San Diego, California, United States
- Clinical Site, Denver, Colorado, United States
- Clinical Site, Boca Raton, Florida, United States
- Clinical Site, Deerfield Beach, Florida, United States
- Clinical Site, Doral, Florida, United States
- Clinical Site, Homestead, Florida, United States
- Clinical Site, Miami, Florida, United States
- Clinical Site, Miami, Florida, United States
- Clinical Site, Miami, Florida, United States
- Clinical Site, Miami, Florida, United States
- Clinical Site, Miami Gardens, Florida, United States
- Clinical Site, Miami Gardens, Florida, United States
Other microbiome trials you might be interested in
Psychosis Associated With Alzheimer's Disease
ML-007C-MA-222 is a 52-week, flexible-dose, open-label extension study designed to evaluate the long-term safety, tolera…
Anaheim, United StatesEst. completion Mar 2029
Psychosis Associated With Alzheimer's Disease
This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled, flexible-dose study evaluating the …
Anaheim, United StatesEst. completion Sep 30, 2028
Clinical Site, Naples, Florida, United StatesClinical Site, Orlando, Florida, United StatesClinical Site, Tampa, Florida, United StatesClinical Site, West Palm Beach, Florida, United StatesClinical Site, Augusta, Georgia, United StatesClinical Site, Snellville, Georgia, United StatesClinical Site, Las Vegas, Nevada, United StatesClinical Site, West Long Branch, New Jersey, United StatesClinical Site, Dayton, Ohio, United StatesClinical Site, Independence, Ohio, United StatesClinical Site, McKinney, Texas, United StatesClinical Site, Sugarland, Texas, United StatesClinical Site, Bellevue, Washington, United StatesClinical Site, Córdoba, Córdoba Province, ArgentinaClinical Site, Córdoba, ArgentinaClinical Site, Pernik, Pernik, BulgariaClinical Site, Sofia, Sofia, BulgariaClinical Site, Brampton, Ontario, CanadaClinical Site, London, Ontario, CanadaClinical Site, Toronto, Ontario, CanadaClinical Site, Lévis, Quebec, CanadaClinical Site, Choceň, CzechiaClinical Site, Prague, CzechiaClinical Site, Toulouse, FranceClinical Site, Pécs, HungaryClinical Site, Pécs, HungaryClinical Site, Roma, ItalyClinical Site, Plewiska, PolandClinical Site, Torres Vedras, Lisbon District, PortugalClinical Site, Bucharest, RomaniaClinical Site, Kragujevac, SerbiaClinical Site, Vranov nad Topľou, SlovakiaClinical Site, Daegu, South KoreaClinical Site, Incheon, South Korea